NCT03390829

Brief Summary

Consultations in general medical practice concerning the follow-up of the patients receiving opiate substitution treatments are not exceptional. It is nowadays agreed that addictive pathology goes far beyond the issue of product dependence, in favor of a pathology in itself. Centered on problems of attachment, of framework, of trust. The implementation of the opiate substitution treatments and the lifting of the product dependence appears only as a preliminary to the background work with the patient ex-user of opiate. Finally, the literature provides little information on the experience of general practitioners and their patients under opiate substitution treatments regarding follow-up consultations in the stability phase. The objective of this work is therefore to study the feelings on follow-up consultations, general practitioners and their patients under opiate substitution treatments considered stabilized.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2017

Completed
1 day until next milestone

Study Start

First participant enrolled

October 20, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 4, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2019

Completed
Last Updated

January 4, 2018

Status Verified

October 1, 2017

Enrollment Period

1.5 years

First QC Date

October 19, 2017

Last Update Submit

December 29, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • assessment of feelings on follow-up consultations with standardized questionnaire

    1 hour

Study Arms (2)

Patients

Other: semi-directed interviews

Doctors

Other: semi-directed interviews

Interventions

semi-directed interviews

DoctorsPatients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients receiving opiate substitution treatments considered stabilized by their GPs

You may qualify if:

  • major people patients receiving opiate substitution treatments

You may not qualify if:

  • considered unstabilized with opiate substitution treatments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Université Angers

Angers, 49100, France

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2017

First Posted

January 4, 2018

Study Start

October 20, 2017

Primary Completion

April 20, 2019

Study Completion

April 20, 2019

Last Updated

January 4, 2018

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations